Print Page
4815
Update on Asthma Treatment: Evidence-Based Recommendations for 2016
Monday, March 7, 2016: 4:45 PM-6:00 PM
Convention Center, Level One, Concourse Hall Room 152
1.25 CME/CE
Workshop - Panel Discussion
Moderator:
Steve N. Georas , MD

Learning Objectives:
  1. Describe current controversies about the use of LABA in asthma, including FDA guidelines about step-down therapy, and describe post-marketing studies currently being conducted to examine LABA safety by comparing LABA/ICS combination inhalers with ICS alone
  2. Discuss and examine the clinical evidence behind use of LAMA in asthma and evidence-based criteria guiding patient selection
  3. Discuss the basis for and practical approaches to step-down therapy once asthma control has been achieved
4:45 PM
Panel Discussion
Panelist
Sally M. Seymour, MD
Handouts
  • Workshop 4815 Asthma Update Clinical Scenarios.pdf (224.4 kB)
    • Panelist
    Matthew A. Rank, MD FAAAAI
    Handouts
  • SD-AAAAI-2016.pdf (114.3 kB)
    • Panelist
    Stanley J. Szefler, MD FAAAAI
    Handouts
  • Szefler Handout AAAAI 030716 4815 Panel.pdf (114.6 kB)
    • 5:30 PM
    Question & Answer
    See more of: Session
    << Previous Session | Next Session >>